Related Experiment Video
Updated: Apr 17, 2026
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
Published on: November 2, 2018
Birdshot retinochoroidopathy review
Clovis Arcoverde Freitas-Neto1, Sutasinee Boonsopon1, Swetha Dhanireddy1
1Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA.
Birdshot retinochoroidopathy (BSRC) is a posterior uveitis. This review highlights BSRC recognition, immune factors, and novel therapies for vision-threatening intraocular disease remission.
Area of Science:
- Ophthalmology
- Immunology
- Genetics
Background:
- Birdshot retinochoroidopathy (BSRC) is a rare posterior uveitis.
- Characterized by choroidopathy, vitritis, and retinal vasculitis.
- Etiology remains largely unknown.
Purpose of the Study:
- Emphasize the importance of recognizing BSRC.
- Discuss recent discoveries and immune mediators.
- Review current and emerging therapies for BSRC remission.
Main Methods:
- Literature review of BSRC.
- Analysis of immune pathways in BSRC.
- Evaluation of therapeutic strategies.
Main Results:
- BSRC diagnosis requires specific clinical findings.
- Immune dysregulation plays a key role in BSRC pathogenesis.
- Multiple treatment options exist, with ongoing research for better outcomes.
Conclusions:
- Early BSRC recognition is crucial for visual preservation.
- Understanding immune mediators can guide targeted therapies.
- Advancements in treatment offer hope for durable BSRC remission.
More Related Videos
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
